Advances in the management of acquired resistance to EGFR-TKI in non-small cell lung cancer

来源 :Oncology and Translational Medicine | 被引量 : 0次 | 上传用户:theonezhaoq
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Drugs that specifically target the tyrosine kinase domain of epidermal growth factor receptor(EGFR), such as erlotinib or gefitinib, have exhibited striking efficacy in non-small cell lung cancer(NSCLC) patients harboring activating EGFR mutations. Howeve
其他文献
Objective Bronchoscopy has been extensively used in the diagnosis of respiratory diseases, and particularly, malignant diseases. However, endoscopists do not no
Objective The aim of this study was to investigate the prognostic relevance of acid phosphatase 1 (ACP1) expression in myeloma patients by using Gene Expression
<正>On Dec.7th,the press conference of Chinese Academy of Science(CAS)was held to announce the latest results of new members election.Prof.Chen Xiao-ping from T
Retropubic radical prostatectomy (RRP) has commonly been performed for localized prostate cancer. In the past decade, with the development of laparoscopic and r
Immunoglobulin G4-related sclerosing cholangitis(Ig G4-SC) is an Ig G4-related disease characterized by bile duct fibroinflammatory wall-thickening and stenosis
The aim of the study was to present two cases that illustrate the beneficial effects of acupuncture on chemotherapy-induced refractory hiccup in cancer patients
Objective Breast cancer is the most frequently diagnosed cancer in women. Accurate evaluation of the size and extent of the tumor is crucial in selecting a suit
Objective The study aimed to detect the expression of estrogen receptors(ERs) in thyroid cancer and investigate the correlation between their expression and cli